According to the research report, the global cell dissociation market size is expected to touch USD 1.8 Billion by 2032, from USD 0.48 Billion in 2022, growing with a significant CAGR of 14.1% from 2023 to 2032.
The cell dissociation report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global cell dissociation in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global cell dissociation market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global cell dissociation during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2867
Report Scope of the Cell Dissociation Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 0.55 Billion |
| Market Size by 2032 | USD 1.8 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 14.1% |
| Largest Market | North America |
| Fastest Growing Market | Asia-Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product Type, By Tissue, By Dissociation, and By End-User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation of the global cell dissociation market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global cell dissociation market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Miltenyi Biotec
- STEMCELL Technologies
- PAN-Biotech
- Danaher Corp.
- Sartorius AG
- BD
- HiMedia Laboratories
- Merck KGaA
- Thermo Fisher Scientific
- S2 Genomics, Inc.
- F. Hoffmann-La Roche Ltd.
Market Segmentation
By Product Type
- Enzymatic Dissociation
- Trypsin
- Hyaluronidase
- Elastase
- Papain
- Collagenase
- DNase
- Others
- Non-enzymatic dissociation
- Instruments & Accessories
By Tissue
- Epithelial Tissue
- Connective Tissue
By Dissociation
- Cell Detachment
- Tissue Dissociation
By End-User
- Academic Institutes & Research Institutes
- Biotechnology Companies & Pharmaceutical Companies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global cell dissociation report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global cell dissociation market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell Dissociation Market
5.1. COVID-19 Landscape: Cell Dissociation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell Dissociation Market, By Product Type
8.1. Cell Dissociation Market Revenue and Volume Forecast, by Product Type, 2023-2032
8.1.1. Enzymatic Dissociation
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Non-enzymatic dissociation
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Instruments & Accessories
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Cell Dissociation Market, By Tissue
9.1. Cell Dissociation Market Revenue and Volume Forecast, by Tissue, 2023-2032
9.1.1. Epithelial Tissue
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Connective Tissue
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Cell Dissociation Market, By Dissociation
10.1. Cell Dissociation Market Revenue and Volume Forecast, by Dissociation, 2023-2032
10.1.1. Cell Detachment
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Tissue Dissociation
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Cell Dissociation Market, By End-User
11.1. Cell Dissociation Market Revenue and Volume Forecast, by End-User, 2023-2032
11.1.1. Academic Institutes & Research Institutes
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Biotechnology Companies & Pharmaceutical Companies
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Cell Dissociation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Tissue (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Dissociation (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End-User (2020-2032)
Chapter 13. Company Profiles
13.1. Miltenyi Biotec
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. STEMCELL Technologies
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PAN-Biotech
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Danaher Corp.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sartorius AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. BD
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. HiMedia Laboratories
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Merck KGaA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Thermo Fisher Scientific
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. S2 Genomics, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments